Evidence map›Paper›PMID 33147451›Full record

ArticleCell reports2020

HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon.

Jonathan J Miner, Derek J Platt, Cyrus M Ghaznavi, Pallavi Chandra, Andrea Santeford, Amber M Menos, Zhenyu Dong, Erin R Wang, Wei Qian, Elysse S Karozichian and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Dry eye disease in mice activates adaptive corneal epithelial regeneration distinct from constitutive renewal in homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jonathan J MinerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: miner@wustl.edu.
Derek J PlattDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cyrus M GhaznaviDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Pallavi ChandraDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Andrea SantefordDepartment of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Amber M MenosDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Zhenyu DongDepartment of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Erin R WangDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Wei QianDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Elysse S KarozichianDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jennifer A PhilipsDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Rajendra S ApteDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: apte@wustl.edu.
Washington University in St. Louis · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Steven Bassnett · 1985 to 2026
$18.4M
Mechanisms of Innate Immune Evasion by Mycobacterium TuberculosisR01AI130454 · NIAID · WASHINGTON UNIVERSITY · PI JENNIFER A PHILIPS · 2017 to 2026
$5.9M
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIAR01AI087682 · NIAID · WASHINGTON UNIVERSITY · PI PHILIPS, JENNIFER A · 2011 to 2022
$4.9M
Mechanisms of STING-associated immunodeficiencyR01AI143982 · NIAID · WASHINGTON UNIVERSITY · PI Jonathan J Miner · 2019 to 2026
$4.6M
MAXIMIZING STUDENT DIVERSITY IN THE BIOMEDICAL SCIENCES AT WASHINGTON UNIVERSITYR25GM103757 · NIGMS · WASHINGTON UNIVERSITY · PI SKEATH, JAMES BENJAMIN · 2013 to 2022
$4.5M
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYER01EY019287 · NEI · WASHINGTON UNIVERSITY · PI APTE, RAJENDRA S · 2010 to 2021
$3.9M
Contributions of IRF5 to Chikungunya Viral ArthritisK08AR070918 · NIAMS · WASHINGTON UNIVERSITY · PI MINER, JONATHAN J · 2017 to 2021
$612k
The Role of SLAMF1 in TB ImmunityR21AI155380 · NIAID · WASHINGTON UNIVERSITY · PI PHILIPS, JENNIFER A · 2020 to 2021
$433k
PATHOGENESIS OF OCULAR ZIKA VIRUS INFECTIONR21EY027870 · NEI · WASHINGTON UNIVERSITY · PI APTE, RAJENDRA S, MINER, JONATHAN J · 2017 to 2018
$419k
NCATS NIH HHS UL1 TR002345NEI NIH HHS P30 EY002687NEI NIH HHS R01 EY019287NEI NIH HHS R21 EY027870NIAID NIH HHS R01 AI087682NIAID NIH HHS R01 AI130454NIAID NIH HHS R01 AI143982NIAID NIH HHS R21 AI155380NIAMS NIH HHS K08 AR070918NIGMS NIH HHS R25 GM103757NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Here, we report our studies of immune-mediated regulation of Zika virus (ZIKV), herpes simplex virus 1 (HSV-1), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the human cornea. We find that ZIKV can be transmitted via corneal transplantation in mice. However, in human corneal explants, we report that ZIKV does not replicate efficiently and that SARS-CoV-2 does not replicate at all. Additionally, we demonstrate that type III interferon (IFN-λ) and its receptor (IFNλR1) are expressed in the corneal epithelium. Treatment of human corneal explants with IFN-λ, and treatment of mice with IFN-λ eye drops, upregulates antiviral interferon-stimulated genes. In human corneal explants, blockade of IFNλR1 enhances replication of ZIKV and HSV-1 but not SARS-CoV-2. In addition to an antiviral role for IFNλR1 in the cornea, our results suggest that the human cornea does not support SARS-CoV-2 infection despite expression of ACE2, a SARS-CoV-2 receptor, in the human corneal epithelium.

Indexed as

AnimalsBetacoronavirusCorneaCoronavirus InfectionsCOVID-19Herpes SimplexHerpesvirus 1, HumanHumansInterferon LambdaInterferonsMicePandemicsPneumonia, ViralSARS-CoV-2Virus ReplicationZika VirusInterferon LambdaInterferonscorneacoronavirusCOVID-19eyeherpes simplex virusinterferon lambdaSARS-CoV-2type III interferonZika virus

Identifiers

PMID33147451
PMCPMC7608022
OpenAlexW3095485663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.